Wait for the next 4C.I think we will be pleasantly surprised regarding revenue growth.I know Tesserent has a "sales" focus, and that the sales team have been working extremely hard.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025